Treatment of Lung Cancer with Orally Administered Chinese Herbal Medicine: An Evidence Map between 1970–2020
- 3 March 2022
- journal article
- research article
- Published by Springer Science and Business Media LLC in Chinese Journal of Integrated Medicine
- Vol. 28 (10), 1-9
- https://doi.org/10.1007/s11655-022-3465-3
Abstract
Objective Through showing the full picture of double-arm controlled clinical research and systematic review evidence in the field of orally administrated Chinese herbal medicine (CHM) for treatment of lung cancer, to provide a reference for future clinical research and to indicate a direction for future systematic reviews. Methods A comprehensive search of clinical controlled studies was performed regarding orally administered CHM treatment for lung cancer published from January 1970 to September 2020. The language was restricted to Chinese and English. Relevant data were extracted, the quality of systematic reviews was evaluated, and the research evidence was visually displayed. Results Randomized controlled trials were the most common type of research design. The research sample sizes were typically small. Oral CHM showed certain curative advantages in treating lung cancer. The key stages in oral CHM intervention for lung cancer are chemotherapy, radiotherapy, and late palliative treatment. The advantageous outcomes of oral CHM treatment of lung cancer are the short-term efficacy, quality of life, and adverse reactions. The perioperative stage, overall survival, pharmacoeconomic evaluation, and Chinese medicine decoctions are weak research areas. Conclusions CHM has staged and therapeutic advantages in treating lung cancer. The overall methodological quality is poor, and the level of evidence requires improvement. It is necessary to carry out large-scale, standardized, and higher-quality research in the superior and weak areas of CHM treatment of lung cancer.Keywords
This publication has 41 references indexed in Scilit:
- Sleep, School Performance, and a School-Based Intervention among School-Aged Children: A Sleep Series Study in ChinaPLOS ONE, 2013
- The Efficacy of Chinese Herbal Medicine as an Adjunctive Therapy for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysisPLOS ONE, 2013
- Patients' Expectations about Effects of Chemotherapy for Advanced CancerThe New England Journal of Medicine, 2012
- Shenqi fuzheng, an injection concocted from chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic reviewJournal of Experimental & Clinical Cancer Research, 2010
- Small studies: strengths and limitationsEuropean Respiratory Journal, 2008
- A clinical study on global TCM therapy in treating senile advanced non-small cell lung cancerChinese Journal of Integrated Medicine, 2007
- Proposal for the Use of Progression-Free Survival in Unblinded Randomized TrialsJournal of Clinical Oncology, 2007
- Complementary and alternative medicine use in lung cancer patients in eight European countriesComplementary Therapies in Clinical Practice, 2006
- Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomized TrialsJournal of Clinical Oncology, 2006
- Why Most Published Research Findings Are FalsePLoS Medicine, 2005